Related Experiment Videos
Atrial diagnostics in a tiered therapy implantable defibrillator
C Tang1, M Schwartz, J A Yeung-Lai-Wah
1Department of Medicine, University of British Columbia, St Paul's Hospital, Vancouver.
The Canadian Journal of Cardiology
|May 1, 1997
Summary
Dual chamber sensing in implantable defibrillators aids in distinguishing ventricular and supraventricular tachycardias. This diagnostic approach confirmed ventricular tachycardias in a patient, guiding effective arrhythmia management.
Area of Science:
- Cardiology
- Biomedical Engineering
- Electrophysiology
Background:
- Implantable defibrillators (ICDs) are crucial for managing life-threatening arrhythmias.
- Differentiating between ventricular tachycardia (VT) and supraventricular tachycardia (SVT) with wide QRS complexes can be challenging.
- Dual chamber sensing offers potential for improved tachycardia discrimination in ICDs.
Observation:
- A patient presented with recurrent wide QRS complex tachycardias at varying rates.
- This patient received a tiered therapy implantable defibrillator equipped with atrial sensing capabilities.
- Continuous monitoring revealed distinct electrophysiological patterns during tachycardic episodes.
Findings:
- Atrial diagnostic data provided clear differentiation between VT and SVT.
- The ICD successfully identified the patient's specific type of ventricular tachycardia.
- The accurate diagnosis directly influenced and guided therapeutic decisions for the patient's arrhythmia.
Implications:
- Dual chamber sensing enhances the diagnostic accuracy of implantable defibrillators.
- Improved tachycardia discrimination can lead to more appropriate and effective therapy delivery.
- This technology holds promise for optimizing arrhythmia management and patient outcomes.